AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 FEB 21 - (NewsRx.com & NewsRx.net) -- A Health Canada Expert Advisory Panel recommends that health care providers not use DEHP containing devices in the treatment of pregnant women, breastfeeding mothers, infants, males before puberty, and patients undergoing cardiac bypass, hemodialysis, or heart transplant surgery.
In a report that was finalized on January 11, 2002, and posted on the Health Canada website, the expert panel also named certain patient groups and medical procedures that require urgent action. Alternate measures are immediately justifiable and should be introduced as quickly as possible, the report said, to protect those subpopulations at greatest risk, namely the fetus, newborns, infants, and young children receiving transfusions, ECMO, cardiopulmonary bypass, exchange transfusion, hemodialysis, TPN (total parenteral nutrition), and lipophilic drug formulations.
The Health Canada report follows a September 2001 U.S. Food and Drug Administration (FDA) Safety Assessment on DEHP (di-2-ethylhexyl-phthalate), the plasticizer used to soften PVC medical products such as bags and tubing. The US report found that DEHP may not be safe for infants, children and adults receiving certain medical treatments that involve PVC medical devices.
"The Health ...
Source: HighBeam Research, Plasticizer in PVC Medical Devices May Harm Developing Babies, Boys,...